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Daniele Di Mascio, MD; Gabriele Saccone, MD; Federica Bellussi, MD;
Huda B. Al-Kouatly, MD; Roberto Brunelli, MD; Pierluigi Benedetti Panici, MD;
Marco Liberati, MD; Francesco D’Antonio, MD; Vincenzo Berghella, MDOBJECTIVE: The aim of this systematic review and meta-analysis of randomized controlled
trials was to evaluate the effect of delayed versus immediate pushing in the second stage of
labor on mode of delivery and other outcomes in women with neuraxial analgesia.
DATA SOURCES: The research was conducted using MEDLINE, EMBASE, Web of Sciences,
Scopus, ClinicalTrial.gov, OVID, and the Cochrane Library as electronic databases, from the
inception of each database to August 2019. No restrictions for language or geographic location
were applied.
STUDY ELIGIBILITY CRITERIA: Selection criteria included only randomized controlled
trials in pregnant women randomized to either delayed or immediate pushing during the
second stage of labor.
STUDY APPRAISAL AND SYNTHESIS METHODS: The primary outcome was mode of
delivery. The summary measures were reported as relative risk or as mean difference with
95% confidence intervals using the random effects model of DerSimonian and Laird. An I2
(Higgins I2) value of greater than 0% was used to identify heterogeneity.Introduction
Several variables in management of the
second stage of labor have been shown
to influence maternal and perinatal
outcomes, such as parity, use of neu-
raxial analgesia or of oxytocin, maternal
characteristics, fetal position, and
birthweight, and therefore many strate-
gies for proper management of the sec-
ond stage have been evaluated.1e3
Timing of pushing in the second stage
is controversial. Women can push soon
after the diagnosis of complete cervical
dilatation when the second stage starts,
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RESULTS: Twelve randomized controlled trials, including 5445 women with neuraxial anal-
gesia randomized to delayed versus immediate pushing during the second stage of labor, were
included in the meta-analysis. Of the 5445 women included in the meta-analysis, 2754 were
randomized to the delayed pushing group and 2691 to the immediate pushing group. No
significant difference between delayed and immediate pushing was found for spontaneous
vaginal delivery (80.9% versus 78.3%; relative risk, 1.05; 95% confidence interval,
1.001.10; 12 randomized controlled trials, 5540women), operative vaginal delivery (12.8%
versus 14.6%; relative risk, 0.89; 95% confidence interval, 0.751.08; 11 randomized
controlled trials, 5395 women), and cesarean delivery (6.9% versus 7.9%; relative risk, 0.89;
95% confidence interval, 0.731.07; 11 randomized controlled trials; 5395women).Women
randomized to the delayed pushing group had a significantly shorter length of active pushing
(mean difference, 27.54 minutes; 95% confidence interval, 43.04 to 12.04; 7 ran-
domized controlled trials, 4737women) at the expense of a significantly longer overall duration
of the second stage of labor (mean difference, 46.17 minutes; 95% confidence interval,
32.6359.71; 8 studies; 4890 women). The incidence of chorioamnionitis (9.1% versus
6.6%; relative risk, 1.37, 95% confidence interval, 1.041.81; 1 randomized controlled trial,
2404 women) and low umbilical cord pH (2.7% versus 1.3%; relative risk, 2.00; 95% con-
fidence interval, 1.303.07; 5 randomized controlled trials, 4549 women) were significantly
higher in the delayed pushing group.
CONCLUSION: In women with spontaneous or induced labor at term with neuraxial
analgesia, delayed pushing in the second stage does not affect the mode of delivery,
although it reduces the time of active pushing at the expense of a longer second stage.
This prolongation of labor was associated with a higher incidence of chorioamnionitis and
low umbilical cord pH. Based on these findings, delayed pushing cannot be routinely
advocated for the management of the second stage.
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Why was this study conducted?
There is conflicting evidence about the effectiveness and safety of delayed versus
immediate pushing in the second stage of labor.
Key findings
Delayed pushing during the second stage of labor did not affect the mode of
delivery, although it reduced the time of active pushing at the expense of a longer
second stage. The incidence of chorioamnionitis and low umbilical cord pH were
significantly higher in the delayed pushing group.
What does this add to what is known?
Ourmeta-analysis shows that delayed pushing in the second stage in women with
uncomplicated, singleton pregnancies and neuraxial analgesia does not affect the
mode of delivery, although it reduces the time of active pushing at the expense of a
longer second stage. This prolongation of labor was associated with a higher
incidence of chorioamnionitis and low umbilical cord pH. Based on these find-
ings, delayed pushing cannot be routinely advocated for the management of the
second stage.
FIGURE 1
Flow diagram of studies identified in the systematic review (Preferred
Reporting Item for Systematic Reviews and Meta-analyses [PRISMA]
template)
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the effect of these 2 different approaches
is conflicting. A prior meta-analysis
showed that delayed pushing in women
with neuraxial analgesia was associated
with an increased incidence of sponta-
neous vaginal delivery, a reduction in the
time of active pushing and with a longer
second stage,4 whereas a recent large
randomized controlled trial (RCT) did
not show a significant effect of delayed
pushing on the mode of delivery and
instead reported an association with
chorioamnionitis and postpartum
hemorrhage.5
Objective
The aim of this systematic review and
meta-analysis of RCTs was to evaluate
the effect of delayed vs immediate
pushing in the second stage of labor on
themode of delivery and other outcomes
in women with neuraxial analgesia.
Materials and Methods
Search strategy
This meta-analysis was performed ac-
cording to a protocol recommended for
systematic reviews.6 The review protocol
was designed a priori defining methods
for collecting, extracting and analyzing
data. The research was conducted using
MEDLINE, EMBASE, Web of Sciences,
Scopus, ClinicalTrial.gov, OVID, and the
Cochrane Library as electronic data-
bases. The trials were identified with the
use of a combination of the following
text words: “immediate pushing” OR
“delayed pushing” AND “second stage”
OR “labor” AND “delivery” and ran-
domized controlled trial as publication
type, from the inception of each database
to August 2019. Review of articles also
included the abstracts of all references
retrieved from the search. No re-
strictions for language or geographic
location were applied.
Study selection
Selection criteria included only RCTs of
pregnant women randomized to delayed
vs immediate pushing in the second
stage of labor. We included only RCTs
reporting mode of delivery as an
outcome. Quasi-randomized trials (ie,
trials in which allocation was done on
FIGURE 2
Assessment of risk of bias. (A) Summary of risk of bias for each trial. Plus sign denotes low risk of bias; minus
sign, high risk of bias; question mark, unclear risk of bias. (B) Risk of bias graph about each risk of bias item
presented as percentages across all included studies
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FIGURE 3
Funnel plot for the risk of publication bias
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Systematic Review ajog.orgthe basis of a pseudo-random sequence,
eg, odd/even hospital number or date of
birth, alternation) were excluded.
Risk of bias assessment
The risk of bias in each included study
was assessed by using the criteria out-
lined in the Cochrane Handbook for
Systematic Reviews of Interventions.7
Seven domains related to risk of bias
were assessed in each included trial, as
there is evidence that these issues are
associated with biased estimates of
treatment effect: 1) random sequence
generation; 2) allocation concealment;
3) blinding of participants and
personnel; 4) blinding of outcome
assessment; 5) incomplete outcome
data; 6) selective reporting; and 7) other
bias. Review authors’ judgments were
categorized as “low risk,” “high risk,” or
“unclear risk” of bias. 7
Primary and secondary outcomes
The primary outcome was mode of de-
livery, including spontaneous vaginal
delivery (SVD), operative vaginal de-
livery (OVD), cesarean delivery (CD),
and operative delivery (OD), defined as
either OVD or CD. We also performed a4 American Journal of Obstetrics& Gynecology Mpost hoc subgroup analysis on SVD by
duration of pushing delay. The second-
ary outcomes were overall duration of
the second stage of labor, time of active
pushing in the second stage of labor,
chorioamnionitis, intrapartum fever
(defined as a maternal temperature of
38C), endometritis, postpartum
hemorrhage (PPH) (defined as a blood
loss of 500 mL after vaginal birth or
1000 mL after CD, or as defined by
authors), rate of episiotomy and severe
perineal lacerations (third degree or
higher), low umbilical cord pH (as
defined by authors), Apgar score of<7 at
5 minutes, respiratory morbidity
(defined as the presence of respiratory
distress syndrome, respiratory diffi-
culties, or need for intubation), and
admission to the neonatal intensive care
unit (NICU).
Data extraction
Two authors (DDM, GS) independently
assessed inclusion criteria, risk of bias,
data extraction, and data analysis. Dis-
agreements were resolved by discussion
with a third reviewer (VB). Data from
each eligible study were extracted
without modification of original dataONTH 2020onto custom-made data collection
forms. Differences were reviewed, and
further resolved by common review of
the entire process.
Quality of the body of evidence
Overall quality of the body of evidence
for the primary and secondary outcomes
was assessed by using the GRADE
criteria (study limitations [ie, risk of
bias], consistency of effect, imprecision,
indirectness, and publication bias).7
Data analysis
Data analysis was completed using Re-
view Manager 5.3 (Copenhagen: The
Nordic Cochrane Center, Cochrane
Collaboration, 2014). The summary
measures were reported as summary
relative risk (RR) or as summary mean
difference (MD) with 95% of confidence
interval (CI) using the random effects
model of DerSimonian and Laird. An I2
(Higgins I2) value greater than 0% was
used to identify heterogeneity.
Potential publication biases were
assessed graphically by using the funnel
plot.
The meta-analysis was reported
following the Preferred Reporting Item
for Systematic Reviews and Meta-
analyses (PRISMA) statement.8
Results
Study selection and study
characteristics
A total of 5445 women with neuraxial
analgesia in 12 RCTs, randomized dur-
ing the first or second stage of labor
to either delayed or immediate pushing
during the second stage of labor,
were included in the meta-analysis
(Figure 1).5,9e19 Of the 5445 women
included in the meta-analysis, 2754
(50.6%) were randomized to the delayed
pushing group and 2691 (49.4%) to the
immediate pushing group.
Most of the included studies used a
computer-generated table of random
numbers and had low to moderate risk
of bias in “incomplete outcome data.”
No method of blinding as to group
allocation was reported (Figure 2).
Publication bias was not apparent by
funnel plot analysis (Figure 3).
TABLE 1
Characteristics of the included trials
Goodfellow
19799
Buxton
198810
Vause
199811
Mayberry
199912
Fraser
200013
Fitzpatrick
200214
Hansen
200215
Plunkett
200316
Simpson
200517
Gillesby
201018
Kelly
201019
Cahill
20185 Total
Study
Location
UK UK UK USA Canada Ireland USA USA USA USA USA USA —
Sample size 37 (21 vs 16) 41 (22 vs 19) 135 (68 vs
67)
153 (81 vs
72)
1862 (936 vs
926)
178 (88 vs
90)
252 (130 vs
122)
202 (117 vs
85)
45 (23 vs 22) 77 (38 vs 39) 59 (26 vs 33) 2404 (1204
vs 1200)
5445 (2754
vs 2691)
Population Nulliparous;
singleton;
term;
vertex
Nulliparous/
multiparous;
singleton;
term;
vertex
Nulliparous;
singleton;
term;
vertex
Nulliparous;
singleton;
term;
vertex
Nulliparous;
singleton;
term;
vertex
Nulliparous;
singleton;
term;
vertex
Nulliparous/
multiparous;
singleton;
term;
vertex
Nulliparous;
singleton;
term;
vertex
Nulliparous;
singleton;
term;
vertex
Nulliparous;
singleton;
term;
vertex
Nulliparous;
singleton;
term;
vertex
Nulliparous;
singleton;
term;
vertex
—
Nulliparous
womena
21/21 vs
16/16
20/23 vs
16/19
68/68 vs
67/67
81/81 vs
72/72
936/936 vs
926/926
88/88 vs
90/90
64/130 vs
65/122
117/117 vs
85/85
23/23 vs
22/22
38/38 vs
39/39
26/26 vs
33/33
1204/1204 vs
1200/1200
2686/2755
(97.5%) vs
2631/2691
(97.8%)
Spontaneous
onset of
labora
21/21 vs
16/16
17/23 vs
13/19
NR NR 654/936 vs
634/926
55/88 vs
65/90
NR 94/117 vs
53/85
0/23 vs 0/22 22/38 vs
21/39
NR 652/1204 vs
642/1200
1515/2450
(61.8%)vs
1444/2397
(60.2%)
Maternal age
(mean)a
NR 24.9  4.8
vs 23.5 
4.1
36.1 vs 27.8 NR 27.6  5.0
vs 27.7 
4.8
30 (18-40) vs
28 (18-38)
NR 29.9  5.7
vs 29.9 
6.1
27.2  5.7
vs 23.7 
5.2
24.9  5.2
vs 25.4 
5.1
28.1  1.0
vs 28.6 
0.8
26.6  6.2
vs 26.5 
5.9
28.16 vs
26.64
Gestational
age (mean)a
NR 39.5  1.3
vs 39.8 
1.0
40.19 vs
40.14
NR 39.4  1.2
vs 39.5 
1.2
40.86 vs
40.57
NR 39.9  1.1
vs 40.1 
1.2
NR NR 40.8  0.3
vs 39.9 
0.2
39.4  1.2
vs 39.5 
1.2
40.0 vs 39.9
Neuraxial
analgesia
4-10 mL
0.25%
Bupivacaine
NR NR 0.12-0.25 mg
Bupivacaine;
Fentanyl
0.125%
Bupivacaine;
Fentanyl
0.1%
Bupivacaine;
Fentanyl
Bupivacaine Combined
spinal-
epiduralb
0.125%
Bupivacaine;
fentanyl
NR 0.125%
Bupivacaine;
Fentanyl
NR -
Oxytocin use
in second
stagea
21/21 vs 16/
16
12/23 vs 12/
19
43/68 vs
40/67
NR NR 71/88 vs 76/
90
NR NR 23/23 vs 22/
22
24/38 vs 28/
39
NR 936/1201 vs
956/1199
1130/1462
(77.3%) vs
1150/1452
(79.2%)
Definition of
low umbilical
cord pH
NR Arterial
umbilical
cord pH<7.2
Venous
umbilical
cord pH
<7.25
NR Arterial <7.1
and/or
venous
<7.15
umbilical cord
pH
NR NR Arterial
umbilical cord
pH <7.1
NR NR NR Arterial
umbilical cord
pH <7.1
—
Time of
randomization
At the
beginning of
the second
stage of labor
At the
beginning of
the second
stage of labor
During the
first stage of
labor or
within 1 h
from full
dilatation
During the
first stage of
labor
At the
beginning of
the second
stage of labor
At the
beginning of
the second
stage of labor
During the
first stage of
labor
At the
beginning of
the second
stage of labor
At the
beginning of
the second
stage of labor
At the
beginning of
the second
stage of labor
During the
first stage of
labor
At the
beginning of
the second of
labor
—
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TABLE 1
Characteristics of the included trials (continued)
Goodfellow
19799
Buxton
198810
Vause
199811
Mayberry
199912
Fraser
200013
Fitzpatrick
200214
Hansen
200215
Plunkett
200316
Simpson
200517
Gillesby
201018
Kelly
201019
Cahill
20185 Total
Intervention Delayed
pushing for up
to 1 h;
Increase in
oxytocin
Delayed
pushing for
up to 3 h or
until the
vertex
became
visible
Delayed
pushing for
up to 3 h or
until the
vertex
became
visible
Delayed
pushing
either after 1
h or in the
presence of
involuntary
pressure /
urge to bear
down
Delayed
pushing for
2 h unless
the patient
felt an
irresistible
urge to push
or the fetal
head was
seen during
inspection of
perineum
Delayed
pushing up to
1 h
Delayed
pushing up to
2 h in
nulliparous
and 1 hour in
multiparous
or until the
head was
seen at the
introitus
Delayed
pushing until
feeling a
strong urge to
push or up to
90 min
Delayed
pushing until
feeling a
strong urge to
push or up to
2 h
Delayed
pushing until
feeling a
strong urge to
push or up to
2 ho
Delayed
pushing until
feeling a
strong urge to
push or up to
90 min
Delayed
pushing for 1
h or until
feeling a
strong urge to
push
—
Control Pushing
immediately
after
diagnosis of
full cervical
dilatation; no
increase in
oxytocin
Pushing
immediately
after
diagnosis of
full cervical
dilatation
Pushing
within 1 h,
whether the
vertex was
visible or
not
Pushing
immediately
after
diagnosis of
full cervical
dilatation
Pushing
immediately
after
diagnosis of
full cervical
dilatation
Pushing
immediately
after
diagnosis of
full cervical
dilatation
Pushing
immediately
after
diagnosis of
full cervical
dilatation
Pushing
immediately
after
diagnosis of
full cervical
dilatation
Pushing
immediately
after
diagnosis of
full cervical
dilatation
Pushing
within 15 min
after
diagnosis of
full cervical
dilatation
Pushing
immediately
after
diagnosis of
full cervical
dilatation
Pushing
immediately
after
diagnosis of
full cervical
dilatation
—
Main outcome Mode of
delivery
Duration of
second stage
Mode of
delivery
Mode of
delivery
Rate of
difficult
delivery
Mode of
delivery
Duration of
second stage
Total pushing
time
Fetal well-
being
Total pushing
time
Total pushing
time
Rate of
spontaneous
vaginal
delivery
—
Intention to
treat
Yes Yes No Yes Yes Yes No Yes Yes Yes No Yes —
NR, not reported.
a Data are presented as total number or as mean  standard deviation (number in the delayed pushing group vs number in the immediate pushing group); b Bupivacaine 2.5 mg/fentanyl 25 mg; epidural: 0.125%; bupivacaine; fentanyl.
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TABLE 2
Exclusion criteria of the trials included in the review
Exclusion criteria
Goodfellow
19799
Women with inadequate analgesia or complications such as fetal distress
Buxton 198810 Occult fetal acidosis before randomization
Vause 199811 Women with a nonvertex presentation, or any complication that might influence second stage management, such as raised blood
pressure, heart disease, or a dural tap
Mayberry
199912
Evidence of fetal complication before randomization
Fraser 200013 Women already pushing spontaneously; fever with a temperature >38C; pregnancy complication such as hypertension, recent
hemorrhage, suspicion of fetal malformation, or intrauterine growth restriction; any condition that necessitated shortening of the
second stage of labor
Fitzpatrick
200214
Patients with diabetes, irritable bowel syndrome, or other bowel or neurological disorder
Hansen 200215 Refusal of epidural; first epidural dose after complete dilatation; known fetal anomaly; multiple gestation; nonvertex presentation;
gestational age<37 wk or>42 wk; pregnancy complications such as pregnancy-induced hypertension, heart disease, or insulin-
dependent diabetes
Plunkett
200316
Women with gestational or pre-gestational diabetes mellitus or a contraindication to pushing in the second stage
Simpson
200517
Women with medical or obstetric complications or a maternal condition that could potentially influence oxygen saturation, including
history of smoking, asthma, chronic or acute pulmonary disease, or cardiac disease
Gillesby 201018 Scheduled cesarean delivery; administration of magnesium sulfate therapy, and/or maternal cardiac condition; maternal weight
275 lb
Kelly 201019 First epidural dose after complete dilation; known fetal anomaly before birth; multiple gestation; nonvertex presentation; maternal
heart disease; administration of magnesium sulfate; poor comprehension of English
Cahill 20185 Multiparous patients; scheduled cesarean deliveries; multiple gestations; major fetal anomalies; nonreassuring fetal status
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with uncomplicated, singleton preg-
nancies and vertex presentation
(Tables 1 and 2). Nulliparous women
represented 96.3% of the sample size. All
the studies included women admitted
for spontaneous or induced labor at
term (3742 weeks of gestation), except
1 trial, which included women from 36
weeks of gestation.18 The most
commonly used neuraxial technique for
labor analgesia was epidural analgesia
with bupivacaine, often combined with
fentanyl.
Women were mainly (8/12, 67%)
randomized at the beginning of the
second stage,5,9,10,13,14,16e18 when com-
plete (10-cm) cervical dilatation was
reached, or during the first stage of labor
(3/12, 25%).12,15,19 In 1 study, women
were randomized during the first stage
or within 1 hour from the diagnosis of
full dilatation.11Women randomized in the interven-
tion group were instructed to delay
pushing from 1 hour to as many as 3
hours unless they felt an irresistible urge
to push, if the fetal head was seen during
obstetric examination of the perineum,
or in case of any medical indication.
Women randomized in the control
group were invited to start pushing
immediately after the diagnosis of com-
plete cervical dilatation,5,9,10,12e17,19 or
within 15 minutes in 1 trial18 and 1 hour
in another trial.11 Of the 4
studies11,12,15,19 that randomized
women in the first stage, 2 reported data
as intention to treat,11,12 and 2 excluded
those who had CD before complete
dilatation,15,19 as they could not receive
the intervention. In 3 of these
studies,11,15,19 when the number of de-
liveries before the second stage was re-
ported, the incidence was 6.7% (30/446).
Therefore, it was impossible to do anMONTH 2020intention-to-treat analysis for all the
trials, or to exclude those who delivered
before the second stage.
Synthesis of results
For the primary outcome, we found no
significant difference between delayed
and immediate pushing for either SVD
(80.9% vs 78.3%; RR, 1.05; 95% CI,
1.001.10 [Figure 4]; 12 RCTs, 5540
women), OVD (12.8% vs 14.6%; RR,
0.89; 95% CI, 0.731.08 [Figure 5]; 11
RCTs, 5395 women), CD (6.9% vs 7.9%;
RR, 0.89; 95% CI, 0.751.07 [Figure 6];
11 RCTs, 5395 women) or OD (19.1% vs
21.2%; RR, 0.91; 95% CI, 0.781.05
[Figure 7]; 12 RCTs, 5440 women)
(Table 3). No difference was found also
when considering only CD performed in
the second stage (5.5% vs 6.2%; RR,
0.90; 95% CI, 0.731.12).
Women randomized to the delayed
pushing group had a significantlyAmerican Journal of Obstetrics& Gynecology 7
FIGURE 4
Forest plot for the risk of spontaneous vaginal delivery
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Systematic Review ajog.orgshorter length of active pushing
(MD 27.54 minutes; 95% CI, 43.04
to 12.04 [Figure 8]; 7 RCTs, 4737
women) at the expense of a significantly
higher overall duration of the second
stage (MD 46.17 minutes; 95% CI,
32.6359.71 [Figure 9]; 8 RCTs, 4890
women). The rate of chorioamnionitis
was significantly higher in the delayed
pushing group (9.1% vs 6.6%; RR, 1.37;
95% CI, 1.041.81 [Figure 10]; 1 RCT,FIGURE 5
Forest plot for the risk of operative va
Di Mascio. Delayed vs immediate pushing in second stage of lab
8 American Journal of Obstetrics& Gynecology M2404 women), although these results
were obtained from a single RCT
(Table 3).
Regarding secondary maternal out-
comes, no difference between interven-
tion and control groups was found in the
rate of intrapartum fever, endometritis,
PPH, episiotomy, and severe perineal
lacerations. Regarding neonatal out-
comes, a significantly higher incidence
of low umbilical cord pH was found inginal delivery
or in women with neuraxial analgesia. Am J Obstet Gynecol 20
ONTH 2020the delayed pushing group (2.7% vs
1.3%; RR, 2.00; 95% CI, 1.303.07
[Figure 11]; 5 RCTs, 4549 women) with
no difference in Apgar score <7 at 5
minutes, respiratory morbidity, or
admission to the NICU (Table 3).
Quality of evidence
The quality of evidence for the primary
and secondary outcomes as assessed by
the GRADE criteria was low, because it20.
FIGURE 6
Forest plot for the risk of cesarean delivery
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ajog.org Systematic Reviewwas downgraded by 1 level for incon-
sistency and 1 level of indirectness due to
the high heterogeneity within the
included trials.
Post hoc subgroup analyses
At the post hoc subgroup analysis on
SVD by duration of pushing delay, we
found a significantly higher rate of SVD
(81.1% vs 75.7%; RR, 1.07; 95% CI,
1.021.12) when pushing was delayed
for 2 hours, whereas no difference was
found when assessing other durations of
delay (Table 4).FIGURE 7
Forest plot for the risk of operative d
Di Mascio. Delayed vs immediate pushing in second stage of labIn subgroup analyses including only
the 10 trials that enrolled only nullipa-
rous women,5,9,11e14,16e19 delayed
pushing compared to immediate push-
ing was associated with similar rates of
SVD (81.0% vs 78.6%; RR, 1.03; 95%CI,
1.00 1.06) and CD (7.3% vs 8.2%; RR,
0.90; 95% CI, 0.761.08).
Post hoc sensitivity analyses
A post hoc sensitivity analysis for only
US trials5,12,15e19 showed that delayed
pushing compared to immediate push-
ing was associated with similar rates ofelivery, either operative vaginal delivery
or in women with neuraxial analgesia. Am J Obstet Gynecol 20
MONTH 2020SVD (84.1% vs 82.2%; RR, 1.05; 95%CI,
0.991.11) and CD (6.5% vs 7.5%; RR,
0.88; 95% CI, 0.681.14).
Comment
Main findings
In this meta-analysis of 12 RCTs
including 5445 mostly nulliparous
women with uncomplicated singleton
gestations, vertex, at or near term, with
neuraxial analgesia, delayed pushing
during the second stage of labor was not
associated with a significant increase in
the rate of SVD or with a reduction in theor cesarean delivery
20.
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TABLE 3
Primary and secondary outcomes
Goodfellow
19799
Buxton
198810
Vause
199811
Mayberry
199912
Fraser
200013
Fitzpatrick
200214
Hansen
200215
Plunkett
200316
Simpson
200517
Gillesby
201018
Kelly
201019
Cahill
20185 Total
RR or MD
(95% CI) I2
GRADE
quality of
evidencea
SVD 12/21 vs
4/16
6/22 vs
11/19
34/68 vs
32/67
58/81 vs
46/72
769/936 vs
718/926
46/88 vs
50/90
111/127 vs
93/122
82/117 vs
59/85
11/23 vs
10/22
30/37 vs
25/39
24/26 vs
29/33
1041/1203
vs 1031/
1200
2224/2749
(80.9%) vs
2108/2691
(78.3%)
1.05
(1.00
e1.10)
33% Low
OVD 9/21 vs
12/16
16/22 vs
7/19
25/68 vs
29/67
20/81 vs
21/72
120/936 vs
155/926
39/88 vs
35/90
16/127 vs
26/122
28/117 vs
16/85
NR 6/37 vs
12/39
0/26 vs 0/
33
71/1203 vs
76/1200
350/2726
(12.8%) vs
389/2669
(14.6%)
0.89
(0.73
e1.08)
47% Low
CD 0/21 vs
0/16
0/22 vs
1/19
9/68 vs
6/67
3/81 vs
5/72
47/936 vs
53/926
3/88 vs
5/90
0/127 vs
3/122
7/117 vs
10/85
NR 1/37 vs
2/39
2/26 vs
4/33
91/1203 vs
93/1200
188/2,726
(6.9%) vs
211/2669
(7.9%)
0.89
(0.75
e1.07)
0% Low
ODb 9/21 vs
12/16
16/22 vs
8/19
34/68 vs
35/67
23/81 vs
26/72
167/936 vs
208/926
42/88 vs 40/
90
16/127 vs
29/122
35/117 vs
26/85
12/23 vs
12/22
7/37 vs
2/39
2/26 vs
4/33
162/1,203
vs 169/
1,200
525/2,749
(19.1%) vs
571/2691
(21.2%)
0.91
(0.78
e1.05)
40% Low
CD in the
second d
stagec
0/21 vs
0/16
0/22 vs
1/19
1/68 vs
2/67
NR 47/936 vs
53/926
3/88 vs
5/90
0/127 vs
3/122
2/117 vs
2/85
NR 1/37 vs
2/39
0/26 vs
0/33
91/1,203 vs
93/1200
145/2,645
(5.5%) vs
161/2597
(6.2%)
0.90
(0.73
e1.12)
0% Low
Duration of
second stage
NR 209 
81 vs
118 
50
214 (149
e252) vs
119 (89
e155)
119.65 
65.32 vs
105.97 
73.48
193.5 
65.88 vs
135.75 
57.75
120 (57
e225) vs
60 (0e148)
116.95 
44.18 vs
49.94 
32.04e
99 (48
e160) vs
69 (42
e135)
139  39
vs 101 
55.9
166.3 
64.2 vs
107.2 
56.3
117.6 
12.1 vs
87.1 
8.6
134.2 
76.3 vs
102.4 
79.6
46.17f
(32.63
e59.71)
93% Low
Time of active
pushing
NR 79  44
vs 81 
48
52 (31e90)
vs 73
(48e115)
NR 82 
46.08 vs
136.25 
73.5
56 (8e130)
vs 60 (0
e148)
35.46 
29.19 vs
49.94 
32.04e
57 (34
e126) vs
62 (33
e112v)
59  25.4
vs 101 
55.9
68.2 
46.2 vs
93.8 
56.9
38.9 
6.9 vs
78.7 
7.9
74.5 
70.7 vs
83.7 
76.8
e27.54f
(e43.04,
e12.04)
96% Low
Chorioamnionitis NR NR NR NR NR NR NR NR NR NR NR 110/1,204
vs 80/1,200
110/1,204
(9.1%) vs
80/1,200
(6.6%)
1.37f
(1.04
e1.81)
— Low
Intrapartum
fever
NR NR NR NR 80/936 vs
42/926
NR NR 23/117 vs
18/85
NR NR NR NR 103/1,053
(9.8%) vs
60/1,011
(5.9%)
1.36
(0.68
e2.73)
78% Low
Endometritis NR NR NR NR NR NR 0/127 vs
0/122
NR NR NR NR 4/1,204 vs
7/1,200
4/1,331
(0.3%) vs
7/1,322
(0.5%)
0.57
(0.17
e1.94)
— Low
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TABLE 3
Primary and secondary outcomes (continued)
Goodfellow
19799
Buxton
198810
Vause
199811
Mayberry
199912
Fraser
200013
Fitzpatrick
200214
Hansen
200215
Plunkett
200316
Simpson
200517
Gillesby
201018
Kelly
201019
Cahill
20185 Total
RR or MD
(95% CI) I2
GRADE
quality of
evidencea
PPH NR NR 12/68 vs
11/67
NR 163/936 vs
155/926
NR NR 3/117 vs 2/
85
NR NR NR 48/1,204 vs
27/1,200
226/2325
(9.7%) vs
195/2278
(8.6%)
1.21
(0.90
e1.63)
30% Low
Episiotomy NR NR 40/68 vs
42/67
NR 380/936 vs
387/926
61/85 vs 66/
85
NR NR NR 4/38 vs
7/39
NR NR 485/1,127
(43%) vs
502/1,117
(44.9%)
0.95
(0.87
e1.04)
0% Low
Severe perineal
lacerations
NR NR NR 5/81 vs
5/72
87/936 vs
88/926
6/85 vs 9/85 NR 11/117 vs
10/85
NR 0/38 vs
3/39
1/26 vs
2/33
558/1,204
vs 551/
1,200
668/2,488
(26.8%) vs
668/2,440
(27.4%)
1.00
(0.92
e1.08)
0% Low
Low umbilical cord
pHd
NR 3/23 vs
0/19
4/18 vs
3/23
NR 37/934 vs
15/926
NR NR 5/117 vs 3/
85
NR NR NR 14/1,204 vs
9/1,200
63/2296
(2.7%) vs
30/2253
(1.3%)
2.00f
(1.30
e3.07)
0% Low
Apgar <7 at 5 min NR 0/22 vs
0/19
0/68 vs
0/67
NR NR NR NR 0/117 vs
2/85
NR NR NR NR 0/207 (0%)
vs 2/171
(1.2%)
0.15
(0.01
e3.00)
— Low
Neonatal
respiratory
morbidity
NR NR 0/68 vs
1/67
NR 26/934 vs
28/926
NR NR NR NR NR NR 25/1,204 vs
30/1200
51/2206
(2.3%) vs
59/2193
(2.7%)
0.86
(0.60
e1.25)
0% Low
NICU admission NR NR 5/68 vs
3/67
NR 46/934 vs
47/926
NR NR 2/117 vs
3/85
NR NR NR 78/1,204 vs
63/1,200
131/2323
(5.6%) vs
116/2278
(5.1%)
1.12
(0.88
e1.42)
0% Low
Data are presented as total number or as mean  standard deviation (number in the delayed pushing vs immediate pushing group).
CD, cesarean delivery; CI, confidence interval; MD, mean difference; NICU, neonatal intensive care unit; NR, not reported; OD, operative delivery; OVD, operative vaginal delivery; PPH, postpartum hemorrhage; RR, relative risk; SVD, spontaneous vaginal delivery.
a Downgraded by 1 level for inconsistency and 1 level of indirectness because of the high heterogeneity within the included trials; b Operative delivery, either operative vaginal delivery or cesarean delivery; c Cesarean deliveries performed in the second stage of labor;
d As defined by study (see Table 1); e Mean time between nulliparous and multiparous women; f Statistically significant.
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FIGURE 8
Forest plot for the mean of length of active pushing
Di Mascio. Delayed vs immediate pushing in second stage of labor in women with neuraxial analgesia. Am J Obstet Gynecol 2020.
Systematic Review ajog.orgincidence of operative and cesarean de-
livery. Delayed pushing significantly
shortened the time of active pushing,
increasing the overall duration of the
second stage. The rate of chorioamnio-
nitis and low umbilical cord pH were
significantly higher in the delayed
pushing group, whereas other maternal
and neonatal outcomes were not signif-
icantly affected by the timing of pushing
in the second stage of labor.
Comparison with existing literature
Different prior reviews have been pub-
lished on this topic (Table 5). A 2017
Cochrane review on timing and tech-
nique for pushing in the second stage of
labor showed that delayed pushing was
associated with an increase in the inci-
dence of SVD and no difference in the
rates of OVD and CD. Despite a higher
incidence of low umbilical cord pH,FIGURE 9
Forest plot for the mean of total leng
Di Mascio. Delayed vs immediate pushing in second stage of lab
12 American Journal of Obstetrics& GynecologyApgar score and NICU admission rates
were found to be similar in both the
delayed and immediate pushing groups.4
Results in terms of mode of delivery in
3 more meta-analyses20e22 reported a
modest but significant increase in SVD
in 2 studies,20,21 whereas no difference in
CD and OVD rates was reported in all
except 1 study,21 which showed a 33%
reduction in OVD in the delayed push-
ing group.
All meta-analyses were consistent in
demonstrating a significant increase in
the overall duration of second stage and
shortening of the time of active pushing
associated with delayed pushing.4,20e22
When focusing on maternal and
neonatal outcomes, the above-
mentioned meta-analyses20e22 demon-
strated no significant difference between
delayed and immediate pushing in the
rate of adverse events, except for 1th of the second stage of labor
or in women with neuraxial analgesia. Am J Obstet Gynecol 20
MONTH 2020review,20 which reported a 2-fold higher
incidence of maternal fever among
women who delayed pushing in a
doseeresponse relationship with the
duration of delay; this might be related
to the higher rate of chorioamnionitis
that was found in the present meta-
analysis, although the incidence of
intrapartum fever and endometritis was
similar in both groups in our study.
Indeed, it has been reported that a large
RCT disagrees with prior meta-analyses
of smaller RCTs 35% of the time.23
Strengths and limitations
Our study has several strengths. This
meta-analysis included all RCTs pub-
lished so far on the topic. To our
knowledge, no prior meta-analysis on
the timing of pushing in the second stage
of labor is as up-to-date or comprehen-
sive. In addition, publication bias was20.
FIGURE 10
Forest plot for the risk of chorioamnionitis
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ajog.org Systematic Reviewnot apparent by funnel plot analysis.
These are key elements that are needed to
evaluate the reliability of a meta-
analysis.7
Limitations of our study are mostly
inherent to the limitations of the
included studies. The quality of evidence
as well as the quality of the included trials
was moderate. We used a random effect
model in all analyses, given the high
statistical heterogeneity within the trials.
Two5,13 of the 12 included RCTs
included more than half of the total
sample size. Furthermore, some of the
included studies date back a long time:
changes and advances in the intrapartum
management of the second stage might
make them less relevant currently. In 4
studies,11,12,15,19 some women were
randomized in the first stage and never
reached the second stage of labor. An
intention-to-treat analysis, or an analysis
excluding these women, was not feasible;
however, the number of women ran-
domized before the second stage was
6.7% in the 3 studies11,15,19 that reported
these numbers, and this represents onlyFIGURE 11
Forest plot for the risk of low umbilic
Di Mascio. Delayed vs immediate pushing in second stage of lab0.6% (30/5445) of the women included
in the meta-analysis. The definition of
low umbilical cord pH was different in
the studies that reported this outcome,
although all but 1 study11 used arterial
umbilical cord pH <7.2 or less as a
threshold to define low pH. In 1 study,
womenwere randomized during the first
stage or within 1 hour from the diagnosis
of full dilatation.11More than the 40% of
the included women came from 1 large
RCT.5 Finally, because of small sample
size and event number, the quality of
evidence for the primary and secondary
outcomes was low.
Implications
An abnormal progression of the second
stage of labor is 1 of the leading in-
dications for CD, and many efforts to
prevent CD in labor are focused on the
second stage.1e3 As we found that
neither delayed pushing nor immediate
pushing in the second stage affected the
mode of delivery, timing of pushing
cannot be considered as an effective
strategy to prevent primary CD in labor.al cord pH
or in women with neuraxial analgesia. Am J Obstet Gynecol 20
MONTH 2020 AIn 2018, the World Health Organiza-
tion (WHO) recommended delayed
pushing for women with neuraxial
analgesia as a practice for a positive
childbirth experience, in the context in
which resources are available for longer
duration in second stage and perinatal
hypoxia can be adequately assessed and
managed.24 This recommendation is
concordant with the 2017 National
Institute of Health and Care Excellence
(NICE) guidelines that suggest delayed
pushing for at least 1 hour in women
with neuraxial analgesia.25 Conversely,
the American College of Obstetricians
and Gynecologists (ACOG) supported,
in 2019, immediate pushing in nullipa-
rous women with neuraxial analgesia,
and highlighted the potential risks of
delayed pushing when counselling pa-
tients who are considering such an
approach.26 In our meta-analysis,
compared to immediate pushing,
delayed pushing in the second stage in
women with neuraxial analgesia was
associated with a significant higher
incidence of chorioamnionitis (although20.
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TABLE 4
Subgroup analysis on spontaneous vaginal delivery by duration of pushing delay
Duration of pushing No. of studies (references) Total RR or MD (95% CI) P value I2
1 h 5 (5, 9, 12, 14, 15)a 1220/1458 (83.7%) vs
1179/1433 (82.3%)
1.05 (0.96e1.14) .26 41%
1.5 h 2 (16, 19) 106/143 (74.1%) vs
88/118 (74.6%)
1.03 (0.91e1.17) .62 0%
2 h 4 (13, 15, 17, 18)a 858/1058 (81.1%) vs
798/1054 (75.7%)
1.07 (1.02e1.12) .003b 0%
3 h 2 (10, 11) 40/90 (44.4%) vs
43/86 (50%)
0.76 (0.35e1.64) .49 70%
CI, confidence interval; MD, mean difference; RR, relative risk.
a Duration of delay in Hansen 2002 was different between nulliparous (2 h) and multiparous (1 h) women, and data were reported accordingly; b Statistically significant.
Di Mascio. Delayed vs immediate pushing in second stage of labor in women with neuraxial analgesia. Am J Obstet Gynecol 2020.
TABLE 5
Results for mode of delivery and primary outcome of the prior meta-analyses
Spontaneous vaginal delivery Instrumental delivery Cesarean delivery Primary outcome Included studies (n) RCTs (n) Non-RCTs (n)
Roberts 200422 NR 0.92 (0.84e1.01) 0.77 (0.55e1.08) Instrumental delivery 9 89e16 127 (letter to editor)
Brancato 200821 1.08 (1.01e1.15) 0.77 (0.71e0.85) 0.80 (0.72e1.07) Spontaneous vaginal delivery 7 711e17 0
Tuuli 201220 1.09 (1.03e1.15) 0.89 (0.76e1.06) 0.85 (0.63e1.14) Spontaneous vaginal delivery 12 119e19 128 (quasi-RCT)
Lemos 20174 1.07 (1.02e1.11) 0.89 (0.74e1.07) 0.83 (0.65e1.05) Duration of second stage 12 119e19 128 (quasi-RCT)
Current review 1.05 (1.00e1.10) 0.89 (0.73e1.08) 0.91 (0.78e1.05) Mode of delivery 12 125,9e19 0
NR, not reported; RCT, randomized controlled trial.
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low umbilical cord pH, with no other
significant maternal or neonatal effect
except longer length of labor and shorter
active pushing phase.
Conclusion
In summary, based on the evidence from
this meta-analysis, delayed pushing
cannot be routinely advocated for the
management of the second stage of la-
bor. Counseling regarding the decision
to push immediately or to delay pushing
for 1 hour or more should include the
risks of longer second stage, cho-
rioamnionitis, and low umbilical cord
pH associated with delayed pushing. -
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